Acquired immunodeficiency syndrome by vertical transmission: Neurological disorders;Síndrome de inmunodeficiencia adquirida por transmisión vertical: Alteraciones neurológicas

Revista de Neurologia

Volumn 36, Issue 3, 2003, Pages 255-263

  Tellechea Rotta, Newra ^a   Legido, A ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Child; Follow up studies; Neuro AIDS

Indexed keywords

ATEVIRDINE; DELAVIRDINE; DIDANOSINE; INDINAVIR; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE DISTRIBUTION; BEHAVIOR DISORDER; BRAIN DISEASE; BRAZIL; BREAST FEEDING; CEREBROVASCULAR ACCIDENT; CHILDHOOD DISEASE; CLINICAL PRACTICE; CONFERENCE PAPER; DEVELOPMENTAL DISORDER; DISEASE TRANSMISSION; EDUCATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; INTRAUTERINE INFECTION; LABORATORY DIAGNOSIS; LYMPHOMA; MENINGOENCEPHALITIS; NEUROLOGIC DISEASE; NEUROLOGICAL COMPLICATION; NUTRITION; OPPORTUNISTIC INFECTION; PERIPHERAL NEUROPATHY; POPULATION RESEARCH; PREGNANCY COMPLICATION; PSYCHOMOTOR DISORDER; RISK FACTOR; SOCIOECONOMICS; SYMPTOMATOLOGY; TREATMENT CONTRAINDICATION; TRYPANOSOMA CRUZI; VERTICAL TRANSMISSION; WESTERN BLOTTING; ADOLESCENT; ADULT; AIDS RELATED COMPLEX; ARTICLE; CHILD; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PREGNANCY; TOXOPLASMOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AIDS DEMENTIA COMPLEX; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD; DEVELOPMENTAL DISABILITIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; NERVOUS SYSTEM DISEASES; PREGNANCY; TOXOPLASMOSIS;

EID: 0037989880     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3603.2002246     Document Type: Conference Paper

References (71)

1. Centers for Disease Control. Classification system for human T-lymphotropic virus type lII/lymphadenopathy-associated virus infection. MMWR, 1986; 35: 334-9.
2. Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984; 224: 500-2.
3. Oleske J, Minnefor A, Cooper Jr R, Thomas K, dela Cruz A, Ahdieh H, et al. Immune deficiency syndrome in children. JAMA 1983; 249: 2345-9.
4. Brasil. Ministério da Saúde. AIDS: Boletim Epidemiológico. Brasília; 1990. p. 9.
5. Snider WD, Simpson DM, Nielsen S, Gold JWM, Metroka CE, Posner JB. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 1983; 14: 403-18.
6. Belman AL, Ultmann MH, Horoupian D, Novick B, Spiro AJ, Rubinstein A, et al. Neurological complications in infants and children with acquired imunne deficiency syndrome. Ann Neurol 1985; 18: 560-6.
7. Epstein LG, Sharer LR, Joshi VV, Fojas MM, Koenigsberger MR, Oleske JM. Progressive encephalopathy in children with acquired immune deficiency syndrome: clinical and neuropathological findings. Ann Neurol 1984; 16: 414.
8. Belman AL, Lantos G, Horoupian D, Novick B, Wisnia A, Ultmann M. Basal ganglionic calcifications in patients with AIDS. Neurology 1985; 35 (Suppl 1): S308.
9. Blanche S, Tardieu M, Duliege AM, Rouzioux C, Le Deist F, Fukunaga K, et al. Longitudinal study of 94 symptomatic infants with perinally acquired HIV infection: evidence for a bimodal expression of clinical and biological symptoms. Am. J. Dis. Child. 1990; 144: 1210-5.
10. Carli C, Civitello LA, Brouwers P, Pizzo PA. The prevalence of computed tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immune deficiency virus. Ann. Neurol. 1993; 34: 198-205.
11. Epstein LG, Sharer LR, Oleske JM, Connor EM, Goudsmit J, Bagdon L, et al. Neurological manifestations of human immunodeficiency virus infection in children. Pediatrics 1986; 78: 678-87.
12. Park YD, Belmann AL, Kim TS, Kure K, Llena JF, Lantos G, et al. Stroke in Pediatric acquired immunodeficiency syndrome. Ann Neurol 1990; 28: 303-11.
13. Rotta NT, Santos BA, Zambom C, Reolon RMK. Aspectos neurológicos em lactente com AIDS. In Lippi JRS, Cruz AR, eds. Neurologia infantil: estudo multidisciplinar. Belo Horizonte; 1987. p. 149-50.
14. Araújo APQ-C. Neurologic findings in Brazilian children with human immunodeficiency virus infection. Pediatric AIDS and HIV Infection: Fetus to Adolescent 1994; 5: 33-4.
15. + Dissertaçao (Mestrado). Porto Alegre: URGS; 1995.
16. Buve A, Rogers MF. AIDS 1998. Epidemiology: overview. AIDS; 1998. 12 Suppl A: S53-4.
17. O'Brien WA. Genetic and biologic basis of HIV-1 neurotropism. In Price RW, Perry SW, eds. HIV, AIDS and the brain. New York: Raven Press; 1994. p. 47-70.
18. Rachid M, Schechter M. Manual de HIV/AIDS. Rio de Janeiro: Revinter, 1998.
19. Machado LR. Processos infecciosos do sistema nervoso. In Nitrini R, Bacheschi LA eds. A neurologia que todo médico deve saber. São Paulo: Maltese; 1991.
20. Pantaleo G, Graziozi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993; 328: 327-35.
21. Levy JA. HIV pathogenesis and long-term survival. AIDS 1993; 7: 1401-10.
22. Ho DD, Neumann AV, Perelson AS, Chen W, Leonard JM, Markowitz, M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373: 123-6.
23. Palumbo PE, Kwok S, Waters S, Wesley Y, Lewis D, McKinney N, et al. Viral measurement by polimerase chain reaction-based assays in human immunodeficiency virus-infected infants. J Pediatr 1995; 126: 592-5.
24. Epstein LG, Gendelman HE. Human immunodeficiency virus type 1 infection of the nervous system: pathogenic mechanisms. Ann Neurol 1993; 33: 429-36.
25. Peudenier S, Hery C, Montagnier L, Tardieu M. Human microglial cell: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. Ann Neurol 1991; 29: 152-61.
26. Benveniste, EN. Cytokine circuits in brain implications for AIDS dementia complex. In Price RW, Perry SW, eds. HIV, AIDS and the brain. New York: Raven Press; 1994. p. 71-88.
27. Poli G, Fauci AS. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res Hum Retrovir 1992; 8: 191-7.
28. Belman AL. Neurologic syndromes. Ann. N. Y. Acad. Sci. 1993; 693: 107-22.
29. Marx J. Do spermspread the AIDS virus? Science 1989; 245: 30.
30. Osmond DH, Padian N. Sexual transmission of HIV. In Cohen PT, Sande MA, Volberging PA, eds. The AIDS knowledge base. 2. Boston: Little & Brown; 1994.
31. Thiry I, Sprecher-Goldberger S, Jonckheer T, Levy J, Van De Perre P, Henrivaux P, et al. Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet 1985; 2: 891-2.
32. Centers for Disease Control. Update: acquired immunodeficiency syndrome. United States 1992. MMWR 1993; 42: 547-57.
33. Nkengasong J, Sylla-Koko F, Peeters M, Ellenberger D, Sassan-Morokro M, Ekpini RA, et al. HIV-1 group 0 virus infection in Abidjan, Cote d'Ivoire. AIDS 1998; 12: 1565-6.
34. Rotta NT, Silva CLO, Ohlweiler L, Lago I, Cabral R, Gonçalves F, et al. Manifestaciones neurológicas del sida en la infancia. Rev Neurol 1999; 29: 319-22.
35. Goedert JJ, Duliège AM, Amos CI, Felton S, Biggar RJ. Hith risk of HIV-1 infection for first-born twins. Lancet 1991; 338: 1471-5.
36. Minkoff H, Mofenson LM. The role of obstetric interventions in the prevention of pediatric human immunodeficiency virus infection. Am J Obstet Gynecol 1994; 171: 1167-75.
37. Sprecher S, Soumenkoff G, Puissant F, Degueldre M. Vertical transmission of HIV in a 15-week fetus. Lancet 1986; 2: 288-9.
38. Ehrnst A, Lindgren S, Dictor M, Johansson B, Sönnerborg A, Czajkowski J, et al. HIV in pregnant women and their offspring: evidence for late transmission. Lancet 1991; 338: 203-7.
39. Bélec L, Bouquety JC, Georges AJ, Siopathis MR, Martin PMV. Antibodies to human immunodeficiency virus in the breast milk of healthy, seropositive women. Pediatrics 1990; 85: 1022-6.
40. European Collaborative Study. Natural history of vertically acquired human immunodeficiency virus-1 infection. Pediatrics 1994; 94: 815-9.
41. Simpson B, Andiman W. Difficulties in assigning human immunodeficiency virus-1 infection and seroreversion status in a cohort of HIV-exposed in children using serologic criteria established by the Centers for Disease Control and Prevention. Pediatrics 1994; 93: 840-2.
42. Silva CLO, Machado ARL, Galvão N, Carvalho PRA. Meningite criptocóccica como primeira manifestaçao da síndrome de imunodeficiência adquirida (sida) na infância. In Congresso Brasileiro de Pediatria, 23, Belo Horizonte, 1989.
43. Succi RCM, Iazzetti AV, Barsanti C, Peres LVC, Kenj G, Gomes IM, et al. Transmissão vertical do HIV: análise epidemiológica e clínica de 115 casos seguidos na disciplina de Infectologia Pediátrica da Escola Paulista de Medicina. In Congresso Brasileiro de Infectologia Pediátrica, 9, Porto Alegre, 1994. Temas Livres. Porto Alegre, 1994.
44. Rotta NT, Silva CLO, Colvero M, Schirmer M, Afonso-Galvão N. Neurosida. Rev Neurol 1997; 25: 903-5.
45. Ammann AJ. Human Immunodeficiency virus infection/AIDS in children: the next decade. Pediatrics 1994; 93: 930-5.
46. Evans JA, Marriage SC, Walters MDS, Levin M. Unsuspected HIV infection preseting in first year of life. BMJ 1995; 310: 1235-6.
47. Deeks SG, Smith, M, Holodniy M, Kahn JO. HIV-1 protease inhibitors: a review for clinicians. JAMA 1997; 277: 145-53.
48. Rogers MF, Schochetman G, Hoff R. Advances in diagnosis of HIV infection in infants. In Pizzo PA, Wilfert CM, eds. Pediatric AIDS. 2. ed. Baltimore: Williams & Wilkins; 1994. p. 219-38.
49. Centers for Disease Control. Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR, 1987; 36: 1-15.
50. Epstein LG, Sharer LR, Joshi VV, Fojas MM, Koenigsberger MR, Oleske JM. Progressive encephalopathy in children with acquired immune deficiency syndrome. Ann Neurol 1985; 17: 488-96.
51. American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 1991; 41: 778-85.
52. Belman AL. AIDS and pediatric neurology. Pediatr Neurol 1990; 8: 571-603.
53. Msellati P, Lepage P, Hitimana DG, Van Goethem C, Van de Perre P, Dabis F. Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort study in Kigali, Rwanda. Pediatrics 1993; 92: 843-8.
54. Michelet C, Arvieux C, Francois C, Besnier JM, Rogez JP, Breux JP, et al. Opportunistic infections occurring during highly active antiretroviral treatment. AIDS 1998; 12: 1815-22.
55. Mitchell WG. Neurocysticercosis and acquired cerebral toxoplasmosis in children. Seminars in Pediatric Neurology 1999; 6: 267-77.
56. Lucas SB, Peacock CS, Hounnou A, Brattegaard K, Koffi, K, Honde M, et al. Disease in children infected with HIV in Abidjan, Cote d'Ivoire. BMJ 1996; 312: 335-8.
57. Katsetos CD, Fincke JE, Legido A, Lischner HW, De Chadarevian JP, Kaye EM, et al. Angiocentric CD-3(+) T-cell infiltrates in human immunodeficiency virus type 1-associated central nervours system disease in children. Clinical & Diagnostic Laboratory Immunology 1999; 6: 105-14.
58. Walter EB, Drucker RP, McKinney RE, Wilfert CM. Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy. J Pediatr 1991; 119: 152-4.
59. Kravcik S, Gallicano K, Roth V, Cassol S, Hawley-Foss N, Badley A, et al. Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir. J Acquir Immune Defic Syndr 1999; 21: 15.
60. Wood B. Children with acquired immune deficiency syndrome: Radiographic features. Invest Radiol 1992; 27: 964.
61. Cecil KM, Lenkinski RE. Proton NMR spectroscopy in inflammatory and infectious brain disorders. Neuroimaging Clin North Am 1998; 8: 863-80.
62. Hedlund GL, Boyer RS. Neuroimaging of postnatal pediatric central nervous system infections. Seminars in Pediatric Neurology 1999; 6: 299-317.
63. Portegies P. HIV-1, the brain and combination therapy. Lancet 1995; 346: 1244-5.
64. Long KZ, Santos JI. Vitamins and the regulation of the immune response. Pediatric Infectious Disease Journal 1999; 18: 283-90.
65. Patrick L. Nutrients and HIV: part two-vitamins A and E, zinc, B-vitamins, and magnesium. Alternative Medicine Review 2000; 5: 39-51.
66. Melikian G, Mmiro F, Ndugwa C, Perry R, Jackson JB, Garrett E, et al. Relation of vitamin A and carotenoid status to growth failure and mortality among Ugandan infants with human immunodeficiency virus. Nutrition 2001; 17: 567-72.
67. Shah S, Whalen C, Kotler DP, Mayanja H, Namale A, Melikian G, et al. Severity of human immunodeficiency virus infection is associated with decreased phase angle, fat mass and body cell mass in adults with pulmonary tuberculosis infection in Uganda. Journal of Nutrition 2001; 131: 2843-7.
68. Baeten JM, Mostad SB, Hughes MP, Overbaugh J, Bankson DD, Mandaliya K, et al. Selenium deficiency is associated with shedding of HIV-1-infected cells in the female genital tract. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ABREVIAR 2001; 26: 360-4.
69. Semba RD, Miotti PG, Chiphangwi JD, Saah AJ, Canner JK, Dallabetta GA, et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994; 343: 1593-7.
70. Excler JL, Beyrer C. Human immunodeficiency virus vaccine development in developing countries: are efficacy trials feasible? Journal of Human Virology 2000; 3: 193-214.
71. Guenter D, Esparza J, Macklin R. Ethical considerations in international HIV vaccine trials: summary of a consultative process conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS). J Med Ethics 2000; 26: 37-43.